The genetic deletion of EZH2 results in the down-regulation of cyclin D1 in breast cancer [34] and in the up-regulation of p21 in ovarian cancer [35], causing cell cycle arrest at the G1/S phase. Here, CCND1 is linked to breast carcinoma.